Health Technology

Tecsys Bolsters Its Industry Leading End-to-End Elite™ Healthcare Supply Chain Execution Platform with Consolidated Pharmacy Inventory Management

Tecsys Inc. (TSX: TCS), an industry-leading supply chain management software company, today announces another significant milestone to its end-to-end Elite™ Healthcare supply chain execution platform with its end-to-end consolidated pharmacy inventory management solution. Integrating unified visibility and control from the point of reception to the point of use, Tecsys' consolidated pharmacy inventory management solution extends its best-in-class consolidated service center model to pharmaceutical supplies, lending the same sophisticated warehouse, distribution and point of use orchestration software to pharmacy operations.


"As healthcare supply chain continues to move from functional to strategic, it becomes irreconcilable to operate different legs of the supply chain with patchwork solutions that don't speak to each other," explains Chris Jellison, vice president, Pharmacy at Parkview Health.


Tecsys' consolidated pharmacy inventory management solution enables centralized strategic buying, management of pharmaceutical spend and procurement operations. By employing consolidated service center supply chain practices, the software helps to manage and mitigate drug shortages, reduces inventory and waste, and streamlines operations, all while integrating regulated processes to remain DSCSA compliant and optimize 340B programs.


"We already have multiple U.S. health systems who have selected this Tecsys platform, and several more looking to extend supply chain's reach and responsibility into pharmacy," says Peter Brereton, president and CEO at Tecsys. "For years, our customers have been honing their supply chains to ensure front-line healthcare workers are armed to deliver care that is both clinically and financially responsible, and this extension is a savvy step toward holistic management of goods within a health system. If we are serious about trying to root out blind spots in the hospital supply chain, pharmaceutical supplies is an area that stands to bridge those data gaps from an analytics and optimization lens."


The pharmaceutical supply chain typically operates in parallel to medical supply management, running siloed processes to track consumption and traceability as well as manage procurement and demand planning. To address this disconnect, progressive health systems are leveraging their Tecsys-enabled consolidated service centers (CSCs) to centralize pharmacy operations and consolidate supply chain management strategies. Tecsys software is able to reconcile these discrete datasets and procurement strategies under a common platform, providing centralized control and management of all supply chain execution supplies. Consolidated management of a pharmacy's supply chain allows for cost per case and cost per procedure analyses by factoring in pharmaceutical supplies, helping hospitals to optimize reimbursement programs and enable more strategic sourcing.


"Over the last decade, progressive health systems across the U.S. have adopted the CSC model to eliminate waste, streamline processes and tap into economies of scale," says Cory Turner, senior director, Healthcare Strategy. "Bringing pharmacy into that equation means extending much needed control and coordination to an historically bifurcated and disorganized inventory management operation. By applying the same sophistication to pharmacy as medical supplies, health systems are not only able to better orchestrate and analyze their operations, but they also stand to gain financial and clinical benefits as well."


Tecsys' consolidated pharmacy inventory management solution is embedded within the broader Tecsys Elite™ Healthcare portfolio, which combines for the most comprehensive supply chain execution system designed specifically for the healthcare industry. Optimized for the regulatory and operational complexities involved in orchestrating multiple clinical areas with differentiated clinical demands, the system provides unified visibility and control from the point of reception to the point of use.


About Tecsys
Tecsys is a global provider of supply chain solutions that equip the borderless enterprise for growth. Organizations thrive when they have the software, technology and expertise to drive operational greatness and deliver on their brand promise. Spanning healthcare, retail, service parts, third-party logistics, and general wholesale high-volume distribution industries, Tecsys delivers dynamic and powerful solutions for warehouse management, distribution and transportation management, supply management at point of use, retail order management, as well as complete financial management and analytics solutions. Tecsys' shares are listed on the Toronto Stock Exchange under the ticker symbol TCS.

Spotlight

Spotlight

Related News

Health Technology, Digital Healthcare

GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound

Business Wire | October 20, 2023

GE HealthCare announced a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity. PFUS is a non-invasive type of bioelectronic medicine that uses ultrasound to activate the nervous system to stimulate a response that may be able to treat disease. Pre-clinical proof of concept and initial early-stage clinical research suggests that it may impact glucose metabolism in people with diabetes via personalized ultrasound stimulation of nerve pathways. If validated with further clinical evidence, PFUS could represent a non-pharmacologic approach to normalize blood glucose levels in people with type 2 diabetes. The existing technology was developed by a team of scientists at GE HealthCare’s HealthCare Technology and Innovation Center, formerly part of the GE Research Center. said Roland Rott, President and CEO, Ultrasound, GE HealthCare. In an era where diabetes is increasing around the globe, we are enthusiastic about the potential for ultrasound to help people live healthier lives, This collaboration with Novo Nordisk opens a path to evolve ultrasound from a means of screening and diagnosis into therapy, as well. We are eager to validate and further develop this potentially groundbreaking science, as we strive to offer patients alternative treatment options for chronic diseases. [Source – Business Wire] An estimated 540 million adults around the world have diabetes, with type 2 diabetes accounting for more than 90 percent of cases.1 An estimated one in eight individuals will have diabetes in 2045, with significant disease burden in low-and-middle-income countries.1 Given its impact on quality of life and mortality, and with its prevalence increasing at an alarming rate for the past three decades,2 type 2 diabetes is a significant public health burden. Obesity impacts approximately 1 billion people worldwide.3 “We look forward to exploring the potential impact this technology could have on treating people with type 2 diabetes and obesity, as significant unmet needs remain in these diseases in spite of recent advances in care,” said Martin Holst Lange, Executive Vice President and Head of Development at Novo Nordisk. “Although early, the possibilities of using ultrasound for therapeutic purposes are compelling and we welcome our collaboration with GE HealthCare in this truly novel area.” As part of the collaboration, GE HealthCare and Novo Nordisk will contribute their respective expertise in ultrasound medical technology and metabolic disease treatment and management as both parties work together to develop a PFUS solution to improve patient care, building upon the extensive foundational research done to date by the GE HealthCare team. Additional terms of the agreement were not disclosed. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Read More

Health Technology

TeleVox Secures Odeza's Patient Engagement Unit from Ensemble Health

TeleVox | September 11, 2023

TeleVox and Ensemble will provide Ensemble's clients with an all-encompassing healthcare solution, from patient acquisition to post-discharge care. This announcement is yet another significant milestone in TeleVox's continuous rapid growth and expansion journey. This acquisition underscores TeleVox's commitment to strengthening its presence in the healthcare sector as it integrates Odeza's patient engagement business. TeleVox, a distinguished provider of state-of-the-art omnichannel digital patient engagement technology, has completed a significant acquisition by owning the Odeza patient engagement business from Ensemble Health Partners (Ensemble). Ensemble, recognized as a preeminent force in revenue cycle management, specializes in delivering its services to various healthcare institutions, including hospitals, health systems, and physician practices. TeleVox and Ensemble are committed to extending the reach and accessibility of TeleVox's cutting-edge technology to Ensemble's existing customer base. This strategic endeavor aims to deliver healthcare providers an all-encompassing solution that seamlessly caters to a broad spectrum of healthcare requirements, commencing with the initial patient acquisition phase and extending throughout the entirety of the patient journey. This comprehensive approach encompasses not only the discharge process but extends into subsequent phases of aftercare and beyond, equipping healthcare institutions with the essential tools and resources to optimize patient engagement, streamline operational workflows, and elevate the overall quality of care delivery. Additionally, this move positions TeleVox to enhance its capabilities further in providing innovative solutions, enabling healthcare providers to engage with patients in a more comprehensive and technologically advanced manner, ultimately advancing the healthcare industry. Vik Krishnan, President of TeleVox, expressed his welcome to Odeza joining the TeleVox family and highlighted that the acquisition of Odeza's patient engagement business aligns with TeleVox's longstanding commitment to tailored communication solutions for enhancing the patient experience, solidifying TeleVox's position as an industry leader. He also emphasized that making their patient engagement solutions accessible to Ensemble's extensive customer base will enable more healthcare providers to deliver exceptional patient care. Judson Ivy, Founder, President and CEO of Ensemble Health Partners, remarked, "This partnership strengthens each of our positions in the healthcare industry and delivers unmatched value to our customers." Meanwhile, the company unveiled Iris, an AI-powered omnichannel conversational virtual assistant tailored for healthcare providers, in April. The introduction of an automated reputation management solution in the month that followed this significant development gave hospitals, health systems, and physician practices the ability to manage and improve their online presence effectively.

Read More

Health Technology

Emory Healthcare Teams Up with DrFirst to Enhance Medication Adherence

Emory Healthcare | November 06, 2023

Emory Healthcare aims to improve prescription affordability and medication outcomes by offering comprehensive, real-time data, including patient out-of-pocket drug costs. Emory is optimizing clinician workflows and enhancing patient medication adherence with Fuzion through DrFirst's three medication management services. UPMC Health System employs AI-driven virtual assistants to address medication nonadherence, engaging high-risk patients via SMS or robocall messages before and between prescription fills. Emory Healthcare and DrFirst have collaborated to address medication adherence by providing comprehensive data at the point of care, including options for patients to assess out-of-pocket drug costs. Emory aims to aid patients in achieving prescription affordability and enhancing their medication outcomes. Emory Healthcare has implemented three medication management services available within the Fuzion platform by DrFirst, which offer clinicians access to medication histories. This initiative aims to streamline clinician workflows and enhance medication adherence among patients. This development holds importance in its potential to decrease adverse drug events for Emory Healthcare patients and provide them with AI-driven information about prescription costs during medical visits, thereby fostering transparency and informed decision-making. DrFirst's advanced medication management platform can enhance electronic prescribing workflows by optimizing the usability of clinical data. This platform is capable of electronically completing prior authorizations and addressing claim rejections. Furthermore, it provides real-time prescription drug benefits and pricing information, enabling physicians to discuss medication costs with their patients and potentially transition to more cost-effective therapeutic alternatives. This can reduce prescription abandonment rates and, consequently, enhance overall health outcomes. G. Cameron Deemer, CEO of DrFirst, said. For many patients, especially those with chronic conditions, taking their medications as prescribed is vital to positive health outcomes and staying out of the hospital. [Source – Healthcare IT News] DrFirst believes that precise and comprehensive medication data contributes significantly to patient safety. Additionally, presenting an entire year's worth of patient medication history can expedite medication reconciliation procedures for healthcare providers. Furthermore, providing drug-allergy, dosing, and duplicate therapy alerts directly to clinicians at the point of care supplies them with valuable information. The integration of technology aids in rendering clinical data more user-friendly and facilitates smoother workflows, ultimately aiding clinicians and patients in achieving improved medication outcomes. Emory Healthcare is set to implement HIPAA-compliant automated patient messaging for electronic prescription alerts. This system will allow patients to review their prescriptions and receive relevant patient education materials, among other features. As for the broader trend, the adoption of AI for improving medication adherence has demonstrated its effectiveness, leading to positive outcomes in both clinical and financial aspects.

Read More